Singapore markets open in 1 hour 11 minutes

Takeda Pharmaceutical Company Limited (TKPHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
30.92-0.74 (-2.34%)
At close: 02:30PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 48.30B
Enterprise value 77.62B
Trailing P/E 24.14
Forward P/E 10.14
PEG Ratio (5 yr expected) 1.03
Price/sales (ttm)1.77
Price/book (mrq)1.04
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.07

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 317.12%
S&P500 52-week change 316.57%
52-week high 334.47
52-week low 325.07
50-day moving average 330.55
200-day moving average 331.61

Share statistics

Avg vol (3-month) 317.57k
Avg vol (10-day) 312.29k
Shares outstanding 51.55B
Implied shares outstanding 61.56B
Float 81.51B
% held by insiders 11.23%
% held by institutions 141.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.39
Forward annual dividend yield 44.49%
Trailing annual dividend rate 3180.00
Trailing annual dividend yield 3568.54%
5-year average dividend yield 44.39
Payout ratio 493.99%
Dividend date 327 Jun 2010
Ex-dividend date 427 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2023
Most-recent quarter (mrq)29 Jun 2023


Profit margin 7.33%
Operating margin (ttm)15.35%

Management effectiveness

Return on assets (ttm)2.73%
Return on equity (ttm)4.55%

Income statement

Revenue (ttm)4.11T
Revenue per share (ttm)2,647.15
Quarterly revenue growth (yoy)8.90%
Gross profit (ttm)N/A
Net income avi to common (ttm)301.4B
Diluted EPS (ttm)1.28
Quarterly earnings growth (yoy)-14.90%

Balance sheet

Total cash (mrq)316.38B
Total cash per share (mrq)203.52
Total debt (mrq)5.24T
Total debt/equity (mrq)75.74%
Current ratio (mrq)0.99
Book value per share (mrq)4,452.06

Cash flow statement

Operating cash flow (ttm)985.32B
Levered free cash flow (ttm)185.93B